Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2021 Earnings

4AugConfirmed

Q4 2020

Q1 2021

Q2 2021

Q3 2021

-0.54

-0.45

-0.36

-0.27

Details

Expected EPS

-0.31

Actual EPS

-0.27

Surprise EPS

0.04

Surprise Percent

+12.9%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.27 per share for Q3 2021.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.